Stable CDK12 Knock-Out Ovarian Cancer Cells Do Not Show Increased Sensitivity to Cisplatin and PARP Inhibitor Treatment

Cyclin-dependent kinase 12 (CDK12) is a serine/threonine kinase involved in the regulation of RNA polymerase II and in the transcription of a subset of genes involved in the DNA damage response. CDK12 is one of the most mutated genes in ovarian carcinoma. These mutations result in loss-of-function a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chilà, Rosaria, Chiappa, Michela, Guffanti, Federica, Panini, Nicolò, Conconi, Donatella, Rinaldi, Andrea, Cascione, Luciano, Bertoni, Francesco, Fratelli, Maddalena, Damia, Giovanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328802/
https://www.ncbi.nlm.nih.gov/pubmed/35912188
http://dx.doi.org/10.3389/fonc.2022.903536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328802/
https://www.ncbi.nlm.nih.gov/pubmed/35912188
http://dx.doi.org/10.3389/fonc.2022.903536

Ejemplares similares